GlassScriptPhysician profile
Stacy S Cwach
NPI 1790233591
$3,492.41
in general payments reported to CMS, 2019-2025
26 companies · $917 in 2025
The $917 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $430 · 2023: $1,059 · 2024: $1,086 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,062.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $716.70 | 2022-2025 | Mounjaro, Zepbound, Basaglar |
| Amgen INC. | $493.37 | 2022-2025 | Evenity, Prolia, Otezla |
| Pfizer INC. | $401.94 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $346.19 | 2023-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $260.89 | 2022-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.44 | 2022-2025 | Jardiance |
| Astellas Pharma US INC | $151.02 | 2024-2025 | Veozah |
| Daiichi Sankyo INC. | $128.27 | 2022-2024 | Injectafer |
| Vertex Pharmaceuticals Incorporated | $94.85 | 2024-2025 | |
| Exact Sciences Corporation | $84.67 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $83.44 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.71 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $72.14 | 2022 | |
| Abbvie INC. | $62.84 | 2025 | |
| Janssen Pharmaceuticals, INC | $53.15 | 2022-2023 | Xarelto |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $48.82 | 2023-2024 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $44.45 | 2025 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $43.19 | 2022-2025 | Trelegy Ellipta |
| Procept Biorobotics Corporation | $29.38 | 2025 | |
| Sanofi-Aventis U.S. LLC | $23.03 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.55 | 2022 | |
| Medtronic, INC. | $22.05 | 2024 | Minimed 780g |
| Inspire Medical Systems, INC. | $19.52 | 2025 | Inspire |
| Dexcom, INC. | $18.31 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $14.90 | 2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Solventum Corporation | $13.59 | 2024 | Prevena, V.A.C. Dermatac, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Cwach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.